Clinical Trials Browser

Phase 1/2 × Withdrawn × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT05191017 2022-08-05

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Phase 1/2 Withdrawn

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant